259 related articles for article (PubMed ID: 34027867)
41. Perioperative Safety and Effectiveness of Neoadjuvant Therapy with Fluorouracil, Leucovorin, Oxaliplatin, and Docetaxel Plus Apatinib in Locally Advanced Gastric Cancer.
Zhang Y; Zhang B; Yang J; Zhang J; Zhang W
Cancer Manag Res; 2021; 13():2279-2286. PubMed ID: 33732020
[TBL] [Abstract][Full Text] [Related]
42. Operative Results and Perioperative Morbidity After Intensified Neoadjuvant Chemotherapy with FLOT for Gastroesophageal Adenocarcinoma Impact of Intensified Neoadjuvant Treatment.
Ganschow P; Hofmann L; Stintzing S; Heinemann V; Angele M; Werner J; Schulz C
J Gastrointest Surg; 2021 Jan; 25(1):58-66. PubMed ID: 32040809
[TBL] [Abstract][Full Text] [Related]
43. Peripheral venous blood neutrophil-to-lymphocyte ratio predicts survival in patients with advanced gastric cancer treated with neoadjuvant chemotherapy.
Chen L; Zuo Y; Zhu L; Zhang Y; Li S; Ma F; Han Y; Song H; Xue Y
Onco Targets Ther; 2017; 10():2569-2580. PubMed ID: 28553122
[TBL] [Abstract][Full Text] [Related]
44. Effects of Neoadjuvant Chemotherapy Toxicity and Postoperative Complications on Short-term and Long-term Outcomes After Curative Resection of Gastric Cancer.
Wu C; Wang N; Zhou H; Wang T; Mao Q; Zhang X; Zhao D
J Gastrointest Surg; 2020 Jun; 24(6):1278-1289. PubMed ID: 31140064
[TBL] [Abstract][Full Text] [Related]
45. [Does the FLOT regimen a new standard of perioperative chemotherapy for localized gastric cancer?].
Adenis A; Samalin E; Mazard T; Portales F; Mourregot A; Ychou M
Bull Cancer; 2020 Jan; 107(1):54-60. PubMed ID: 31980145
[TBL] [Abstract][Full Text] [Related]
46. Long-term Outcomes of Neoadjuvant Chemotherapy With Docetaxel, Cisplatin and S-1 for Stage III Gastric Cancer.
Kasahara K; Kunisaki C; Sato S; Kondo H; Takahashi M; Tamura Y; Tsuchiya N; Tanaka Y; Sato K; Kimura J; Kosaka T; Ono H; Makino H; Akiyama H; Endo I
Anticancer Res; 2023 Jun; 43(6):2841-2850. PubMed ID: 37247913
[TBL] [Abstract][Full Text] [Related]
47. Different Prognostic Implications of Residual Disease After Neoadjuvant Treatment: Impact of Ki 67 and Site of Response.
Diaz-Botero S; Espinosa-Bravo M; Gonçalves VR; Esgueva-Colmenarejo A; Peg V; Perez J; Cortes J; Rubio IT
Ann Surg Oncol; 2016 Nov; 23(12):3831-3837. PubMed ID: 27357178
[TBL] [Abstract][Full Text] [Related]
48. Feasibility and Safety of Perioperative Chemotherapy With Fluorouracil Plus Leucovorin, Oxaliplatin, and Docetaxel for Locally Advanced Gastric Cancer Patients in China.
Sah BK; Xu W; Zhang B; Zhang H; Yuan F; Li J; Liu W; Yan C; Li C; Yan M; Zhu Z
Front Oncol; 2020; 10():567529. PubMed ID: 33537232
[TBL] [Abstract][Full Text] [Related]
49. Prognostic impact of preoperative platelets to lymphocytes ratio (PLR) on survival for oesophageal and junctional carcinoma treated with neoadjuvant chemotherapy: A retrospective monocentric study on 153 patients.
Messager M; Neofytou K; Chaudry MA; Allum WH
Eur J Surg Oncol; 2015 Oct; 41(10):1316-23. PubMed ID: 26166786
[TBL] [Abstract][Full Text] [Related]
50. Tumor Regression Grade and Overall Survival following Gastrectomy with Preoperative Therapy for Gastric Cancer.
Sinnamon AJ; Savoldy M; Mehta R; Dineen SP; Peña LR; Lauwers GY; Pimiento JM
Ann Surg Oncol; 2023 Jun; 30(6):3580-3589. PubMed ID: 36765008
[TBL] [Abstract][Full Text] [Related]
51. Impact of hormone receptor, HER2, and Ki-67 status conversions on survival after neoadjuvant chemotherapy in breast cancer patients: a retrospective study.
Chen Y; Liu X; Yu K; Sun X; Xu S; Qiu P; Lv Z; Zhang X; Guo A; Xu Y
Ann Transl Med; 2022 Jan; 10(2):93. PubMed ID: 35282081
[TBL] [Abstract][Full Text] [Related]
52. Perioperative Chemotherapy for Gastro-Esophageal or Gastric Cancer: Anthracyclin Triplets versus FLOT.
Geerts JFM; van der Zijden CJ; van der Sluis PC; Spaander MCW; Nieuwenhuijzen GAP; Rosman C; van Laarhoven HWM; Verhoeven RHA; Wijnhoven BPL; Lagarde SM; Mostert B
Cancers (Basel); 2024 Mar; 16(7):. PubMed ID: 38610969
[No Abstract] [Full Text] [Related]
53. Pretreatment platelet-to-lymphocyte ratio is associated with the response to first-line chemotherapy and survival in patients with metastatic gastric cancer.
Wang J; Qu J; Li Z; Che X; Liu J; Teng Y; Jin B; Zhao M; Liu Y; Qu X
J Clin Lab Anal; 2018 Jan; 32(1):. PubMed ID: 28238215
[TBL] [Abstract][Full Text] [Related]
54. A prognostic model based on combining estrogen receptor expression and Ki-67 value after neoadjuvant chemotherapy predicts clinical outcome in locally advanced breast cancer: extension and analysis of a previously reported cohort of patients.
Miglietta L; Morabito F; Provinciali N; Canobbio L; Meszaros P; Naso C; Murialdo R; Boitano M; Salvi S; Ferrarini M
Eur J Surg Oncol; 2013 Oct; 39(10):1046-52. PubMed ID: 23890870
[TBL] [Abstract][Full Text] [Related]
55. Outcome evaluation of ECF, DCF, FOLFOX, and FLOT chemotherapy regimens as perioperative treatment in elderly patients with resectable gastric cancer; A retrospective comparative study.
Forouhari A; Moghaddas A; Darakhshandeh A
J Res Med Sci; 2023; 28():79. PubMed ID: 38292337
[TBL] [Abstract][Full Text] [Related]
56. Prognostic value of pre-operative inflammatory response biomarkers in gastric cancer patients and the construction of a predictive model.
Deng Q; He B; Liu X; Yue J; Ying H; Pan Y; Sun H; Chen J; Wang F; Gao T; Zhang L; Wang S
J Transl Med; 2015 Feb; 13():66. PubMed ID: 25885254
[TBL] [Abstract][Full Text] [Related]
57. Prognostic Value of Systemic Inflammatory Response Markers in Patients Undergoing Neoadjuvant Chemotherapy and Gastrectomy for Advanced Gastric Cancer in the Eastern European Population.
Pikuła A; Skórzewska M; Pelc Z; Mlak R; Gęca K; Sędłak K; Ciseł B; Kwietniewska M; Rawicz-Pruszyński K; Polkowski WP
Cancers (Basel); 2022 Apr; 14(8):. PubMed ID: 35454903
[TBL] [Abstract][Full Text] [Related]
58. Evaluation of the Predictive and Prognostic Values of Stromal Tumor-Infiltrating Lymphocytes in HER2-Positive Breast Cancers treated with neoadjuvant chemotherapy.
Yang X; Rao J; Yang W; Shui R
Target Oncol; 2018 Dec; 13(6):757-767. PubMed ID: 30406444
[TBL] [Abstract][Full Text] [Related]
59. The relationship between platelet-lymphocyte ratio, neutrophil-lymphocyte ratio, and survival in metastatic gastric cancer on firstline modified docetaxel and cisplatinum plus 5 Fluorourasil Regimen: A single institute experience.
Dogan M; Eren T; Ozdemir N; Cigirgan CL; Zengin N
Saudi J Gastroenterol; 2015; 21(5):320-4. PubMed ID: 26458860
[TBL] [Abstract][Full Text] [Related]
60. Neutrophil-to-lymphocyte and platelet-to-lymphocyte ratios predict chemotherapy outcomes and prognosis in patients with colorectal cancer and synchronous liver metastasis.
Wu Y; Li C; Zhao J; Yang L; Liu F; Zheng H; Wang Z; Xu Y
World J Surg Oncol; 2016 Nov; 14(1):289. PubMed ID: 27852294
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
